查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1421832

週期性發燒綜合症市場、份額、規模、趨勢、行業分析報告：按適應症、按治療、按最終用途、按地區、按細分市場、預測，2024-2032年

Periodic Fever Syndrome Market Share, Size, Trends, Industry Analysis Report, By Indication ; By Treatment; By End-Use; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球週期性發燒綜合症市場規模預計將達到8.8195億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

越來越多的政府計畫致力於增加對不常見疾病的了解，推動了這一領域的成長。 研究活動的增加和快速的技術突破正在導致新藥的創造、診斷能力的增強和治療方法的確立，所有這些都對市場成長做出了重大貢獻。 該領域可能會受益於治療這種疾病的新藥的批准。

FMF 是世界上和加拿大最常見的單一自體發炎性疾病，其特徵是反覆發作的發燒和涉及漿膜和滑膜的發炎。 它以體染色體隱性方式遺傳，在中東和地中海血統的人群中發病率最高，在其他種族群體中患病率各不相同。

隱熱蛋白相關週期性症候群 (CAPS) 是一組自體發炎性疾病。 編碼冷熱蛋白的CIAS1基因中的突變會增加白血球介素I和其他細胞因子的活性，其透過稱為Toll樣受體的細胞內受體或核甘酸寡聚結構域蛋白連接來活化目標細胞。

Ilaris 是 FDA 批准的第一個也是唯一一個用於治療 TRAPS、超免疫球蛋白 D 症候群和家族性地中海熱的生物製劑。 這三種疾病都屬於一種罕見的自體發炎性疾病，稱為週期性發燒綜合症。 FMF 是最常見的疾病，主要影響東地中海血統的人。 在不同人群中，每 250 人中就有 1 人到 1,000 人中就有 1 人受其影響，其中大多數是兒童。

為了因應 COVID-19，羥氯奎等常用藥物的需求顯著增加。 由於對 COVID-19 疫苗和治療的需求，生物製藥行業將在未來幾年顯著增長。 預計這將對週期性發燒綜合症市場產生重大影響。 卡那奴單抗最近被批准用於治療週期性發燒綜合徵、冷熱蛋白相關週期性綜合徵、週期性發熱綜合徵和全身性幼年系統性關節炎，這可能會支持週期性發熱綜合徵業務的增長。

週期性發燒綜合症市場報告亮點

皮質類固醇和非類固醇抗發炎藥 (NSAID) 等口服抗發炎藥物用於治療週期性發燒綜合徵，預計在預測期內將佔據重要的市場份額。

由於該地區主要參與者的滲透率不斷提高以及對患者護理和監測的重視程度不斷提高，北美已成為全球週期性發燒綜合徵市場的領導者。

目錄

第 1 章簡介

第 2 章執行摘要

第 3 章研究方法

第 4 章洞察全球週期性發燒症候群市場

  • 週期性發燒綜合症市場 - 治療概況
  • 週期性發燒症候群市場動態
    • 促進因素和機會
      • 基因研究的進展
      • 提高醫療保健專業人員和病患的意識
    • 抑制因素和挑戰
      • 有限的患者群體
  • PESTEL 分析
  • 週期性發燒症候群的市場治療趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第 5 章全球週期性發燒症候群市場：依適應症

  • 主要發現
  • 簡介
  • 高免疫球蛋白血症 D 症候群 (HIDS)
  • 家族性地中海熱 (FMF)
  • TNF 受體相關週期性症候群 (TRAPS)
  • 隱□林相關週期性綜合症
  • 其他

第 6 章全球週期性發燒症候群市場：依最終用途劃分

  • 主要發現
  • 簡介
  • 醫院
  • 零售藥局

第 7 章全球週期性發燒症候群市場：依治療分類

  • 主要發現
  • 簡介
  • 口服抗發炎藥
  • 非類固醇類抗發炎藥 (NSAID)
  • 抗腫瘤壞死因子治療
  • 他汀類藥物
  • 其他

第 8 章全球週期性發燒症候群市場：依地區

  • 主要發現
  • 簡介
    • 2019-2032 年週期性發燒症候群市場評估（按地區）
  • 週期性發燒綜合症市場 - 北美
    • 北美：週期性發燒症候群市場，依適應症劃分，2019-2032 年
    • 北美：週期性發燒症候群市場，依治療方法，2019-2032 年
    • 北美：週期性發燒症候群市場，依最終用途，2019-2032 年
    • 週期性發燒綜合症市場 - 美國
    • 週期性發燒綜合症市場 - 加拿大
  • 週期性發燒綜合症市場 - 歐洲
    • 歐洲：週期性發燒症候群市場，依適應症劃分，2019-2032 年
    • 歐洲：週期性發燒症候群市場，依治療方法，2019-2032 年
    • 歐洲：週期性發燒症候群市場，依最終用途，2019-2032 年
    • 週期性發燒綜合症市場 - 英國
    • 週期性發燒綜合症市場 - 法國
    • 週期性發燒綜合症市場 - 德國
    • 週期性發燒綜合症市場 - 義大利
    • 週期性發燒綜合症市場 - 西班牙
    • 週期性發燒綜合症市場 - 荷蘭
    • 週期性發燒綜合症市場 - 俄羅斯
  • 週期性發燒綜合症市場 - 亞太地區
    • 亞太地區：週期性發燒症候群市場，依適應症劃分，2019-2032 年
    • 亞太地區：週期性發燒症候群市場，依治療方法，2019-2032 年
    • 亞太地區：週期性發燒綜合症市場，依最終用途，2019-2032 年
    • 週期性發燒綜合症市場 - 中國
    • 週期性發燒綜合症市場 - 印度
    • 週期性發燒綜合症市場 - 馬來西亞
    • 週期性發燒綜合症市場 - 日本
    • 週期性發燒綜合症市場 - 印度尼西亞
    • 週期性發燒綜合症市場 - 韓國
  • 週期性發燒綜合症市場 - 中東和非洲
    • 中東和非洲：按症狀劃分的週期性發燒綜合症市場，2019-2032 年
    • 中東與非洲：週期性發燒症候群市場，依治療方法，2019-2032 年
    • 中東和非洲：週期性發燒綜合症市場，按最終用途，2019-2032 年
    • 週期性發燒綜合症市場 - 沙烏地阿拉伯
    • 週期性發燒綜合症市場 - 阿拉伯聯合大公國
    • 週期性發燒綜合症市場 - 以色列
    • 週期性發燒綜合症市場 - 南非
  • 週期性發燒綜合症市場 - 拉丁美洲
    • 拉丁美洲：週期性發燒症候群市場，依適應症劃分，2019-2032 年
    • 拉丁美洲：週期性發燒症候群市場，依治療方法，2019-2032 年
    • 拉丁美洲：週期性發燒症候群市場，依最終用途，2019-2032 年
    • 週期性發燒綜合症市場 - 墨西哥
    • 週期性發燒綜合症市場 - 巴西
    • 週期性發燒綜合症市場 - 阿根廷

第 9 章競爭態勢

  • 擴張與收購分析
    • 擴大
    • 收購
  • 夥伴關係/協作/協議/揭露

第 10 章公司簡介

  • Merck & Co Inc
  • Novartis AG
  • Simvastatin
  • Swedish Orphan Biovitrum AB
Product Code: PM4152

The global periodic fever syndrome market size is expected to reach USD 881.95 million by 2032, according to a new study by Polaris Market Research. The report "Periodic fever syndrome Market Share, Size, Trends, Industry Analysis Report, By Indication (Hyper-immunoglobulinemia D syndrome, Familial Mediterranean Fever, TNF Receptor Associated periodic syndrome, Cryopyrin Associated periodic syndrome, Others); By Treatment; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rise of the sector is being aided by a rise in government programs focused on raising public knowledge of uncommon disorders. Increased research activity and quick technical breakthroughs are resulting in the creation of new medications, enhanced diagnostic capabilities, and treatments, all of which contribute significantly to market growth. The sector is likely to benefit from new medication approvals to treat the condition.

FMF is the most prevalent monogenic autoinflammatory illness in the world and in Canada, with repeated, self-limited bouts of fever and inflammation involving serous and synovial membranes. It is inherited in an autosomal recessive manner, and its incidence is highest among groups of Middle Eastern and Mediterranean ancestry, with varying prevalence in other ethnicities.

Cryopyrin-associated periodic syndrome (CAPS) is a series of autoinflammatory illnesses that are connected. Mutations in the CIASl gene, which encodes cryopyrin, induce the enhanced activity of interleukin I and other cytokines, which activate their target cells via an intracellular receptor known as the Toll-like receptor or nucleotide oligomerization domain protein ligation.

Ilaris is the first and only FDA-approved biologic therapy for TRAPS, Hyper immunoglobulin D Syndrome, & Familial Mediterranean Fever. All three disorders are part of a rare category of auto-inflammatory diseases known as Periodic Fever Syndromes. FMF is the most frequent condition, affecting primarily those of Eastern Mediterranean heritage. It affects 1 in 250 to 1 in 1,000 people in various populations, with a majority of them being children.

Commonly used medications, such as hydroxychloroquine, have seen a huge increase in demand for COVID-19 control. Because of the need for vaccinations and treatment medications for COVID-19, the biopharma industry is likely to increase significantly in the future. This, in turn, is projected to have a major influence on the market for periodic fever syndrome. Recently, Canakinumab has been licensed for the treatment of individuals with periodic fever syndrome, cryopyrin-associated periodic syndrome, periodic fever syndrome, and systemic juvenile systemic arthritis which likely boosts the growth of periodic fever syndrome business.

Periodic Fever Syndrome Market Report Highlights

Oral anti-inflammatory medicines such as corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs), among others, are expected to hold a significant market share over the projection period as these are used to treat periodic fever syndrome.

North America is a market leader in the worldwide periodic fever syndrome sector due to the expanding penetration of the region's key companies and the increased emphasis on patient care and monitoring.

The global players include: Merck & Co Inc, Simvastatin, Swedish Orphan Biovitrum AB, and Novartis AG.

Polaris Market Research has segmented the periodic fever syndrome market report based on indication, treatment, end-use and region:

Periodic Fever Syndrome, Indication Outlook (Revenue - USD Million, 2019 - 2032)

  • Hyperimmunoglobulinemia D syndrome
  • Familial Mediterranean Fever (FMF)
  • TNF Receptor Associated Periodic Syndrome (TRAPS)
  • Cryopyrin Associated Periodic Syndrome
  • Others

Periodic Fever Syndrome, Treatment Outlook (Revenue - USD Million, 2019 - 2032)

  • Oral anti-inflammatory drugs
  • Non-steroidal anti-inflammatory drugs (NSAIDs)
  • Anti-TNF therapy
  • Statins
  • Others

Periodic fever syndrome, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Retail Pharmacy

Periodic fever syndrome, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Periodic Fever Syndrome Market Insights

  • 4.1. Periodic Fever Syndrome Market - Treatment Snapshot
  • 4.2. Periodic Fever Syndrome Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Genetic Research
      • 4.2.1.2. Growing awareness among healthcare professionals, patients
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited Patient Pool
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Periodic Fever Syndrome Market Treatment Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Periodic Fever Syndrome Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • 5.3. HyperimmunoGlobulinemia D syndrome (HIDS)
    • 5.3.1. Global Periodic Fever Syndrome Market, by HyperimmunoGlobulinemia D syndrome (HIDS), by Region, 2019-2032 (USD Million)
  • 5.4. Familial Mediterranean Fever (FMF)
    • 5.4.1. Global Periodic Fever Syndrome Market, by Familial Mediterranean Fever (FMF), by Region, 2019-2032 (USD Million)
  • 5.5. TNF Receptor-Associated Periodic Syndrome (TRAPS)
    • 5.5.1. Global Periodic Fever Syndrome Market, by TNF Receptor-Associated Periodic Syndrome (TRAPS), by Region, 2019-2032 (USD Million)
  • 5.6. Cryopyrin-Associated Periodic Syndrome
    • 5.6.1. Global Periodic Fever Syndrome Market, by Cryopyrin-Associated Periodic Syndrome, by Region, 2019-2032 (USD Million)
  • 5.7. Others
    • 5.7.1. Global Periodic Fever Syndrome Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Periodic Fever Syndrome Market, by End-Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Global Periodic Fever Syndrome Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 6.4. Retail Pharmacy
    • 6.4.1. Global Periodic Fever Syndrome Market, by Retail Pharmacy, by Region, 2019-2032 (USD Million)

7. Global Periodic Fever Syndrome Market, by Treatment

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • 7.3. Oral anti-inflammatory drugs
    • 7.3.1. Global Periodic Fever Syndrome Market, by Oral anti-inflammatory drugs, By Region, 2019-2032 (USD Million)
  • 7.4. Non-steroidal anti-inflammatory drugs (NSAIDs)
    • 7.4.1. Global Periodic Fever Syndrome Market, by Non-steroidal anti-inflammatory drugs (NSAIDs), By Region, 2019-2032 (USD Million)
  • 7.5. Anti-TNF therapy
    • 7.5.1. Global Periodic Fever Syndrome Market, by Anti-TNF therapy, By Region, 2019-2032 (USD Million)
  • 7.6. Statins
    • 7.6.1. Global Periodic Fever Syndrome Market, by Statins, By Region, 2019-2032 (USD Million)
  • 7.7. Others
    • 7.7.1. Global Periodic Fever Syndrome Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Periodic Fever Syndrome Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Periodic Fever Syndrome Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Periodic Fever Syndrome Market - North America
    • 8.3.1. North America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.3.2. North America: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.3. North America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.3.4. Periodic Fever Syndrome Market - U.S.
      • 8.3.4.1. U.S.: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.3.5. Periodic Fever Syndrome Market - Canada
      • 8.3.5.1. Canada: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.4. Periodic Fever Syndrome Market - Europe
    • 8.4.1. Europe: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.3. Europe: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.4. Periodic Fever Syndrome Market - UK
      • 8.4.4.1. UK: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.5. Periodic Fever Syndrome Market - France
      • 8.4.5.1. France: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.5.3. France: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.6. Periodic Fever Syndrome Market - Germany
      • 8.4.6.1. Germany: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.7. Periodic Fever Syndrome Market - Italy
      • 8.4.7.1. Italy: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.8. Periodic Fever Syndrome Market - Spain
      • 8.4.8.1. Spain: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.9. Periodic Fever Syndrome Market - Netherlands
      • 8.4.9.1. Netherlands: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.4.10. Periodic Fever Syndrome Market - Russia
      • 8.4.10.1. Russia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.5. Periodic Fever Syndrome Market - Asia Pacific
    • 8.5.1. Asia Pacific: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.4. Periodic Fever Syndrome Market - China
      • 8.5.4.1. China: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.4.3. China: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.5. Periodic Fever Syndrome Market - India
      • 8.5.5.1. India: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.5.3. India: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.6. Periodic Fever Syndrome Market - Malaysia
      • 8.5.6.1. Malaysia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.7. Periodic Fever Syndrome Market - Japan
      • 8.5.7.1. Japan: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.8. Periodic Fever Syndrome Market - Indonesia
      • 8.5.8.1. Indonesia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.5.9. Periodic Fever Syndrome Market - South Korea
      • 8.5.9.1. South Korea: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.6. Periodic Fever Syndrome Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.4. Periodic Fever Syndrome Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.5. Periodic Fever Syndrome Market - UAE
      • 8.6.5.1. UAE: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.6. Periodic Fever Syndrome Market - Israel
      • 8.6.6.1. Israel: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.6.7. Periodic Fever Syndrome Market - South Africa
      • 8.6.7.1. South Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • 8.7. Periodic Fever Syndrome Market - Latin America
    • 8.7.1. Latin America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.7.4. Periodic Fever Syndrome Market - Mexico
      • 8.7.4.1. Mexico: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.7.5. Periodic Fever Syndrome Market - Brazil
      • 8.7.5.1. Brazil: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
    • 8.7.6. Periodic Fever Syndrome Market - Argentina
      • 8.7.6.1. Argentina: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Merck & Co Inc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Novartis AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Simvastatin
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Swedish Orphan Biovitrum AB
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development

List of Tables

  • Table 1 Global Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 2 Global Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 3 Global Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 4 Periodic Fever Syndrome Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 6 North America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 7 North America: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 8 U.S.: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 9 U.S.: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 10 U.S.: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 11 Canada: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 12 Canada: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 13 Canada: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 14 Europe: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 15 Europe: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 16 Europe: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 17 UK: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 18 UK: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 19 UK: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 20 France: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 21 France: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 22 France: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 23 Germany: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 24 Germany: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 25 Germany: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 26 Italy: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 27 Italy: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 28 Italy: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 29 Spain: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 30 Spain: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 31 Spain: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 32 Netherlands: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 33 Netherlands: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 34 Netherlands: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 35 Russia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 36 Russia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 37 Russia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 41 China: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 42 China: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 43 China: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 44 India: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 45 India: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 46 India: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 47 Malaysia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 48 Malaysia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 49 Malaysia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 50 Japan: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 51 Japan: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 52 Japan: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 53 Indonesia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 54 Indonesia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 55 Indonesia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 56 South Korea: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 57 South Korea: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 58 South Korea: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 65 UAE: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 66 UAE: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 67 UAE: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 68 Israel: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 69 Israel: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 70 Israel: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 71 South Africa: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 72 South Africa: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 73 South Africa: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 74 Latin America: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 75 Latin America: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 76 Latin America: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 77 Mexico: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 78 Mexico: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 79 Mexico: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 80 Brazil: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 81 Brazil: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 82 Brazil: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)
  • Table 83 Argentina: Periodic Fever Syndrome Market, by Indication, 2019-2032 (USD Million)
  • Table 84 Argentina: Periodic Fever Syndrome Market, by End-Use, 2019-2032 (USD Million)
  • Table 85 Argentina: Periodic Fever Syndrome Market, by Treatment, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Periodic Fever Syndrome Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by End-Use
  • Figure 7. Global Periodic Fever Syndrome Market, by End-Use, 2022 & 2032 (USD Million)
  • Figure 8. Market by Indication
  • Figure 9. Global Periodic Fever Syndrome Market, by Indication, 2022 & 2032 (USD Million)
  • Figure 10. Market by Treatment
  • Figure 11. Global Periodic Fever Syndrome Market, by Treatment, 2022 & 2032 (USD Million)
  • Figure 12. Periodic Fever Syndrome Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Periodic Fever Syndrome Market